Breaking News Instant updates and real-time market news.

AXSM

Axsome Therapeutics

$65.29 /

-0.06 (-0.09%)

, CMPS

Compass Pathways

$37.26 /

+0.6 (+1.64%)

04:55
07/13/21
07/13
04:55
07/13/21
04:55

Cowen to hold a virtual summit

Psychedelics & Novel Mechanisms in Neuropsychiatry Virtual Summit to be held on July 13. Webcast Link

AXSM

Axsome Therapeutics

$65.29 /

-0.06 (-0.09%)

CMPS

Compass Pathways

$37.26 /

+0.6 (+1.64%)

PRX

Now private

$49.98 /

+ (+0.00%)

SAGE

Sage Therapeutics

$53.71 /

-1.02 (-1.86%)

  • 13

    Jul

  • 13

    Jul

  • 15

    Jul

  • 22

    Aug

  • 18

    Sep

  • 30

    Apr

AXSM Axsome Therapeutics
$65.29 /

-0.06 (-0.09%)

06/10/21
Fly Intel: Top five analyst initiations
06/10/21 Berenberg
Berenberg starts Axsome Therapeutics at Buy ahead of 'transformational year'
06/10/21 Berenberg
Axsome Therapeutics initiated with a Buy at Berenberg
04/27/21 H.C. Wainwright
Axsome Therapeutics price target raised to $225 from $210 at H.C. Wainwright
CMPS Compass Pathways
$37.26 /

+0.6 (+1.64%)

07/01/21 H.C. Wainwright
Compass Pathways price target raised to $100 from $65 at H.C. Wainwright
06/28/21
Fly Intel: Top five analyst initiations
06/28/21 Maxim
Compass Pathways initiated with a Buy at Maxim
06/28/21 Maxim
Compass Pathways initiated with a Buy at Maxim
PRX Now private
$49.98 /

+ (+0.00%)

SAGE Sage Therapeutics
$53.71 /

-1.02 (-1.86%)

06/24/21 Piper Sandler
Piper Sandler sees 'asymmetric' risk reward for Sage Therapeutics investors
06/22/21 Mizuho
Sage Therapeutics price target lowered to $60 from $77 at Mizuho
06/16/21
Fly Intel: Top five analyst downgrades
06/16/21 Truist
Sage Therapeutics price target lowered to $60 from $70 at Truist

TODAY'S FREE FLY STORIES

Initiation
Cowen Group initiated with a Sell at Goldman Sachs » 16:26
09/20/21
09/20
16:26
09/20/21
16:26
COWN

Cowen Group

$33.06 /

-1.61 (-4.64%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COWN Cowen Group
$33.06 /

-1.61 (-4.64%)

COWN Cowen Group
$33.06 /

-1.61 (-4.64%)

03/29/21 Compass Point
Cowen Group upgraded to Buy from Neutral at Compass Point
03/25/21 Piper Sandler
Piper 'strongly' believes Cowen pullbacks should be bought
03/25/21 JMP Securities
Cowen Group price target raised to $60 from $36 at JMP Securities
03/23/21 Piper Sandler
Cowen shares remain 'significantly undervalued,' says Piper Sandler
COWN Cowen Group
$33.06 /

-1.61 (-4.64%)

Initiation
First Solar initiated with a Sector Weight at KeyBanc » 16:26
09/20/21
09/20
16:26
09/20/21
16:26
FSLR

First Solar

$95.73 /

-8.3 (-7.98%)

KeyBanc analyst Sophie…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FSLR First Solar
$95.73 /

-8.3 (-7.98%)

FSLR First Solar
$95.73 /

-8.3 (-7.98%)

07:21 Today Credit Suisse
First Solar price target raised to $96 from $80 at Credit Suisse
09/10/21 Needham
First Solar offers differentiated technology but margins to narrow, says Needham
09/09/21 Needham
First Solar initiated with a Hold at Needham
08/31/21 Wolfe Research
First Solar initiated with a Peer Perform at Wolfe Research
FSLR First Solar
$95.73 /

-8.3 (-7.98%)

  • 15
    Dec
FSLR First Solar
$95.73 /

-8.3 (-7.98%)

FSLR First Solar
$95.73 /

-8.3 (-7.98%)

FSLR First Solar
$95.73 /

-8.3 (-7.98%)

Conference/Events
Merck to hold a conference call » 16:25
09/20/21
09/20
16:25
09/20/21
16:25
MRK

Merck

$71.91 /

+0.21 (+0.29%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$71.91 /

+0.21 (+0.29%)

MRK Merck
$71.91 /

+0.21 (+0.29%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley downgrades Merck to Equal Weight, awaits strategic action
09/07/21 Morgan Stanley
Merck downgraded to Equal Weight from Overweight at Morgan Stanley
MRK Merck
$71.91 /

+0.21 (+0.29%)

MRK Merck
$71.91 /

+0.21 (+0.29%)

MRK Merck
$71.91 /

+0.21 (+0.29%)

MRK Merck
$71.91 /

+0.21 (+0.29%)

Initiation
Piper Sandler initiated with a Buy at Goldman Sachs » 16:24
09/20/21
09/20
16:24
09/20/21
16:24
PIPR

Piper Sandler

$131.53 /

-3.47 (-2.57%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PIPR Piper Sandler
$131.53 /

-3.47 (-2.57%)

PIPR Piper Sandler
$131.53 /

-3.47 (-2.57%)

08/31/21 Northland
Piper Sandler price target raised to $161 from $135 at Northland
08/02/21 JMP Securities
Piper Sandler price target raised to $172 from $138 at JMP Securities
12/15/20 Northland
Piper Sandler price target raised to $110 from $87 at Northland
12/10/20 JMP Securities
Piper Sandler price target raised to $106 from $93 at JMP Securities
PIPR Piper Sandler
$131.53 /

-3.47 (-2.57%)

Initiation
Jefferies Financial Group initiated with a Buy at Goldman Sachs » 16:22
09/20/21
09/20
16:22
09/20/21
16:22
JEF

Jefferies Financial Group

$35.91 /

-0.67 (-1.83%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JEF Jefferies Financial Group
$35.91 /

-0.67 (-1.83%)

JEF Jefferies Financial Group
$35.91 /

-0.67 (-1.83%)

01/06/21 Oppenheimer
Jefferies Financial Group price target raised to $32 from $26 at Oppenheimer
01/05/21 Wells Fargo
Goldman Sachs shares to pass all-time high 'soon,' says Wells Fargo
JEF Jefferies Financial Group
$35.91 /

-0.67 (-1.83%)

JEF Jefferies Financial Group
$35.91 /

-0.67 (-1.83%)

JEF Jefferies Financial Group
$35.91 /

-0.67 (-1.83%)

JEF Jefferies Financial Group
$35.91 /

-0.67 (-1.83%)

Conference/Events
Sixth Street management to meet virtually with Oppenheimer » 16:22
09/20/21
09/20
16:22
09/20/21
16:22
TSLX

Sixth Street

$21.77 /

+0.145 (+0.67%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSLX Sixth Street
$21.77 /

+0.145 (+0.67%)

05/06/21 Ladenburg
Sixth Street downgraded to Neutral on valuation at Ladenburg
05/06/21 Ladenburg
Sixth Street downgraded to Neutral from Buy at Ladenburg
04/15/21 Oppenheimer
Sixth Street initiated with an Outperform at Oppenheimer
11/06/20 Raymond James
Sixth Street upgraded to Outperform from Market Perform at Raymond James
TSLX Sixth Street
$21.77 /

+0.145 (+0.67%)

  • 19
    Feb
Hot Stocks
Herc Holdings raises FY21 adjusted EBITDA view to $840M-$870M from $870M-$890M » 16:21
09/20/21
09/20
16:21
09/20/21
16:21
HRI

Herc Holdings

$125.41 /

-4.1 (-3.17%)

Backs FY21 net rental…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HRI Herc Holdings
$125.41 /

-4.1 (-3.17%)

HRI Herc Holdings
$125.41 /

-4.1 (-3.17%)

09/16/21 Baird
Ashtead results positive for United Rentals and Herc, says Baird
07/23/21 Barclays
Herc Holdings price target raised to $135 from $128 at Barclays
07/22/21 Baird
Herc Holdings price target raised to $145 from $135 at Baird
07/14/21 Barclays
Herc Holdings price target raised to $128 from $115 at Barclays
HRI Herc Holdings
$125.41 /

-4.1 (-3.17%)

Hot Stocks
Alerus Financial announces Katie Lorenson to succeed Randy Newman as CEO » 16:20
09/20/21
09/20
16:20
09/20/21
16:20
ALRS

Alerus Financial

$27.80 /

+0.6 (+2.21%)

Alerus Financial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALRS Alerus Financial
$27.80 /

+0.6 (+2.21%)

ALRS Alerus Financial
$27.80 /

+0.6 (+2.21%)

Initiation
Pennant Group initiated with a Buy at Stifel » 16:20
09/20/21
09/20
16:20
09/20/21
16:20
PNTG

Pennant Group

$29.60 /

-1.62 (-5.19%)

Stifel analyst Tao Qiu…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PNTG Pennant Group
$29.60 /

-1.62 (-5.19%)

PNTG Pennant Group
$29.60 /

-1.62 (-5.19%)

08/11/21 RBC Capital
Pennant Group price target lowered to $44 from $50 at RBC Capital
08/11/21 Truist
Pennant Group price target lowered to $35 from $44 at Truist
06/10/21 RBC Capital
RBC Capital upgrades Pennant Group to Outperform on improving demand environment
06/10/21 RBC Capital
Pennant Group upgraded to Outperform from Sector Perform at RBC Capital
PNTG Pennant Group
$29.60 /

-1.62 (-5.19%)

Conference/Events
Achilles Therapeutics management to meet virtually with Oppenheimer » 16:20
09/20/21
09/20
16:20
09/20/21
16:20
ACHL

Achilles Therapeutics

$5.83 /

+0.005 (+0.09%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACHL Achilles Therapeutics
$5.83 /

+0.005 (+0.09%)

ACHL Achilles Therapeutics
$5.83 /

+0.005 (+0.09%)

08/10/21 Piper Sandler
Achilles Therapeutics price target lowered to $23 from $25 at Piper Sandler
06/29/21 Chardan
Iovance data show activity but 'not a home run,' says Chardan
05/19/21 Chardan
Iovance Biotherapeutics price target lowered to $51 from $54 at Chardan
04/26/21 BofA
BofA starts Achilles Therapeutics at Buy on 'unique' cancer platform
ACHL Achilles Therapeutics
$5.83 /

+0.005 (+0.09%)

  • 31
    Mar
ACHL Achilles Therapeutics
$5.83 /

+0.005 (+0.09%)

Options
Closing CBOE SPX and VIX Index summary for September 20th » 16:20
09/20/21
09/20
16:20
09/20/21
16:20
VIX

Volatility Index S&P 500 Options

/

+

The CBOE Volatility Index…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VIX Volatility Index S&P 500 Options
/

+

Conference/Events
Incyte management to meet virtually with Oppenheimer » 16:19
09/20/21
09/20
16:19
09/20/21
16:19
INCY

Incyte

$75.93 /

-0.1 (-0.13%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INCY Incyte
$75.93 /

-0.1 (-0.13%)

INCY Incyte
$75.93 /

-0.1 (-0.13%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/09/21 Benchmark
Sanofi deal for Kadmon reinforces Incyte thesis, says Benchmark
09/01/21 Cowen
Odds of Incyte drug exclusion from class warning 'largely unchanged,' says Cowen
07/20/21 Benchmark
Incyte upgraded to Buy from Hold at Benchmark
INCY Incyte
$75.93 /

-0.1 (-0.13%)

INCY Incyte
$75.93 /

-0.1 (-0.13%)

INCY Incyte
$75.93 /

-0.1 (-0.13%)

INCY Incyte
$75.93 /

-0.1 (-0.13%)

Hot Stocks
Willdan Group awarded $21.2M contract from City of Dublin, California » 16:19
09/20/21
09/20
16:19
09/20/21
16:19
WLDN

Willdan Group

$35.57 /

+0.49 (+1.40%)

Willdan Group announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WLDN Willdan Group
$35.57 /

+0.49 (+1.40%)

WLDN Willdan Group
$35.57 /

+0.49 (+1.40%)

08/06/21 Roth Capital
Willdan Group price target lowered to $45 from $58 at Roth Capital
03/10/21 Roth Capital
Willdan Group price target raised to $58 from $43 at Roth Capital
Hot Stocks
Aprea Therapeutics jumps 15% to $5.60 per share after announcing APR-246 data  16:18
09/20/21
09/20
16:18
09/20/21
16:18
APRE

Aprea Therapeutics

$4.84 /

-0.275 (-5.38%)

 
ShowHide Related Items >><<
APRE Aprea Therapeutics
$4.84 /

-0.275 (-5.38%)

APRE Aprea Therapeutics
$4.84 /

-0.275 (-5.38%)

08/20/21 JPMorgan
JPMorgan downgrades Aprea to Underweight on 'multiple overhangs'
08/20/21 JPMorgan
Aprea Therapeutics downgraded to Underweight from Neutral at JPMorgan
08/16/21 Berenberg
Aprea Therapeutics downgraded to Hold from Buy at Berenberg
08/16/21 H.C. Wainwright
Aprea Therapeutics price target lowered to $4 from $6 at H.C. Wainwright
APRE Aprea Therapeutics
$4.84 /

-0.275 (-5.38%)

APRE Aprea Therapeutics
$4.84 /

-0.275 (-5.38%)

Conference/Events
Pfizer management to meet virtually with Oppenheimer » 16:18
09/20/21
09/20
16:18
09/20/21
16:18
PFE

Pfizer

$44.22 /

+0.325 (+0.74%)

Meeting to be held on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$44.22 /

+0.325 (+0.74%)

PFE Pfizer
$44.22 /

+0.325 (+0.74%)

06:31 Today Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
PFE Pfizer
$44.22 /

+0.325 (+0.74%)

PFE Pfizer
$44.22 /

+0.325 (+0.74%)

PFE Pfizer
$44.22 /

+0.325 (+0.74%)

PFE Pfizer
$44.22 /

+0.325 (+0.74%)

Hot Stocks
Aprea Therapeutics presents data from phase 1/2 trial of APR-246 in solid tumors » 16:18
09/20/21
09/20
16:18
09/20/21
16:18
APRE

Aprea Therapeutics

$4.84 /

-0.275 (-5.38%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APRE Aprea Therapeutics
$4.84 /

-0.275 (-5.38%)

APRE Aprea Therapeutics
$4.84 /

-0.275 (-5.38%)

08/20/21 JPMorgan
JPMorgan downgrades Aprea to Underweight on 'multiple overhangs'
08/20/21 JPMorgan
Aprea Therapeutics downgraded to Underweight from Neutral at JPMorgan
08/16/21 Berenberg
Aprea Therapeutics downgraded to Hold from Buy at Berenberg
08/16/21 H.C. Wainwright
Aprea Therapeutics price target lowered to $4 from $6 at H.C. Wainwright
APRE Aprea Therapeutics
$4.84 /

-0.275 (-5.38%)

APRE Aprea Therapeutics
$4.84 /

-0.275 (-5.38%)

Hot Stocks
Verrica Pharmaceuticals receives CRL from FDA identifying deficiencies at CMO » 16:17
09/20/21
09/20
16:17
09/20/21
16:17
VRCA

Verrica Pharmaceuticals

$12.01 /

-0.045 (-0.37%)

Verrica Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRCA Verrica Pharmaceuticals
$12.01 /

-0.045 (-0.37%)

VRCA Verrica Pharmaceuticals
$12.01 /

-0.045 (-0.37%)

06/17/21 Needham
Verrica Pharmaceuticals's Ycanth offers superior efficacy to Novan, says Needham
06/01/21 Northland
Verrica Pharmaceuticals price target lowered to $19 from $24 at Northland
05/13/21 RBC Capital
Verrica Pharmaceuticals initiated with an Outperform at RBC Capital
03/08/21 H.C. Wainwright
Verrica Pharmaceuticals price target raised to $24 from $21 at H.C. Wainwright
VRCA Verrica Pharmaceuticals
$12.01 /

-0.045 (-0.37%)

  • 23
    Mar
VRCA Verrica Pharmaceuticals
$12.01 /

-0.045 (-0.37%)

VRCA Verrica Pharmaceuticals
$12.01 /

-0.045 (-0.37%)

Technical Analysis
NASDAQ market internals summary » 16:17
09/20/21
09/20
16:17
09/20/21
16:17
$NSD

NASDAQ Market Internals

/

+

Volume was above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Hot Stocks
APA Corp. raises quarterly dividend to 6.25c per share » 16:16
09/20/21
09/20
16:16
09/20/21
16:16
APA

APA Corp.

$18.92 /

-1.215 (-6.03%)

The dividend on APA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APA APA Corp.
$18.92 /

-1.215 (-6.03%)

APA APA Corp.
$18.92 /

-1.215 (-6.03%)

07/20/21 Truist
APA Corp. price target lowered to $20 from $24 at Truist
06/25/21
Fly Intel: Top five analyst downgrades
06/25/21 JPMorgan
APA downgraded to Neutral ahead of appraisal results at JPMorgan
06/25/21 JPMorgan
APA Corp. downgraded to Neutral from Overweight at JPMorgan
APA APA Corp.
$18.92 /

-1.215 (-6.03%)

APA APA Corp.
$18.92 /

-1.215 (-6.03%)

APA APA Corp.
$18.92 /

-1.215 (-6.03%)

Conference/Events
Perion Network management to meet virtually with Oppenheimer » 16:16
09/20/21
09/20
16:16
09/20/21
16:16
PERI

Perion Network

$17.97 /

-0.99 (-5.22%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PERI Perion Network
$17.97 /

-0.99 (-5.22%)

08/03/21 Lake Street
Perion Network price target raised at Lake Street after 'well-executed quarter'
07/01/21 Needham
Perion Network price target raised to $25 from $21 at Needham
06/28/21 Stifel
Perion Network price target raised to $21 at Stifel after preliminary Q2 report
06/28/21 Lake Street
Perion Network price target raised to $29 at Lake Street after pre-announcement
PERI Perion Network
$17.97 /

-0.99 (-5.22%)

  • 20
    Jan
PERI Perion Network
$17.97 /

-0.99 (-5.22%)

PERI Perion Network
$17.97 /

-0.99 (-5.22%)

Hot Stocks
Axalta Coating withdraws FY21 guidance amid supply chain shortages » 16:16
09/20/21
09/20
16:16
09/20/21
16:16
AXTA

Axalta Coating

$27.96 /

-0.61 (-2.14%)

Axalta Coating Systems…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AXTA Axalta Coating
$27.96 /

-0.61 (-2.14%)

AXTA Axalta Coating
$27.96 /

-0.61 (-2.14%)

09/15/21 BofA
Axalta Coating removed from US 1 List at BofA
09/09/21 Citi
Axalta Coating downgraded to Neutral from Buy at Citi
09/09/21 Citi
Axalta Coating downgraded to Neutral from Buy at Citi
07/28/21 Deutsche Bank
Axalta Coating price target lowered to $36 from $38 at Deutsche Bank
AXTA Axalta Coating
$27.96 /

-0.61 (-2.14%)

AXTA Axalta Coating
$27.96 /

-0.61 (-2.14%)

AXTA Axalta Coating
$27.96 /

-0.61 (-2.14%)

Technical Analysis
NYSE market internals summary » 16:16
09/20/21
09/20
16:16
09/20/21
16:16
$NYE

NYSE Market Internals

/

+

Volume was above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

Upgrade
Segro upgraded to Conviction Buy from Buy at Goldman Sachs » 16:15
09/20/21
09/20
16:15
09/20/21
16:15
SEGXF

Segro

$17.36 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SEGXF Segro
$17.36 /

+ (+0.00%)

SEGXF Segro
$17.36 /

+ (+0.00%)

09/01/21 Morgan Stanley
Segro price target raised to 1,350 GBp from 1,100 GBp at Morgan Stanley
08/04/21 JPMorgan
Segro price target raised to 1,250 GBp from 1,195 GBp at JPMorgan
08/02/21 Barclays
Segro price target raised to 1,335 GBp from 1,220 GBp at Barclays
08/02/21 RBC Capital
Segro price target raised to 1,100 GBp from 875 GBp at RBC Capital
Hot Stocks
FedEx Express, FedEx Ground, and FedEx Freight to increase shipping rates » 16:15
09/20/21
09/20
16:15
09/20/21
16:15
FDX

FedEx

$250.85 /

-4.29 (-1.68%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FDX FedEx
$250.85 /

-4.29 (-1.68%)

FDX FedEx
$250.85 /

-4.29 (-1.68%)

09/17/21 UBS
FedEx price target lowered to $380 from $397 at UBS
09/17/21 Baird
FedEx sentiment too negative with favorable outlook, says Baird
09/13/21 KeyBanc
FedEx price target lowered to $350 from $370 at KeyBanc
09/13/21 Citi
FedEx price target lowered to $360 from $365 at Citi
FDX FedEx
$250.85 /

-4.29 (-1.68%)

FDX FedEx
$250.85 /

-4.29 (-1.68%)

FDX FedEx
$250.85 /

-4.29 (-1.68%)

FDX FedEx
$250.85 /

-4.29 (-1.68%)

Conference/Events
Brooklyn ImmunoTherapeutics to hold a conference call » 16:15
09/20/21
09/20
16:15
09/20/21
16:15
BTX

Brooklyn ImmunoTherapeutics

$9.93 /

-2.07 (-17.25%)

Management conducts a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BTX Brooklyn ImmunoTherapeutics
$9.93 /

-2.07 (-17.25%)

BTX Brooklyn ImmunoTherapeutics
$9.93 /

-2.07 (-17.25%)

BTX Brooklyn ImmunoTherapeutics
$9.93 /

-2.07 (-17.25%)

BTX Brooklyn ImmunoTherapeutics
$9.93 /

-2.07 (-17.25%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.